Prestigious Prize Recognizes Groundbreaking Immune System Research
This year's prestigious award in medical science was granted for revolutionary discoveries that clarify how the immune system attacks harmful infections while protecting the body's own cells.
Three esteemed researchers—from Japan Shimon Sakaguchi and American experts Mary Brunkow and Fred Ramsdell—share this honor.
The work uncovered unique "security guards" within the defense system that remove rogue immune cells that could harming the organism.
These discoveries are now enabling new treatments for immune disorders and cancer.
These winners will share a prize fund valued at 11 million SEK.
Crucial Findings
"Their work has been decisive for comprehending how the immune system operates and the reason we do not all suffer from serious self-attack conditions," stated the chair of the Nobel Committee.
This team's research address a fundamental mystery: How does the immune system defend us from countless infections while keeping our healthy cells unharmed?
Our body's protection system employs immune cells that scan for indicators of infection, including viruses and germs it has never encountered.
These defenders employ detectors—known as recognition units—that are generated by chance in countless combinations.
That provides the immune system the capacity to fight a broad range of threats, but the unpredictability of the process unavoidably creates white blood cells that can target the host.
Security Guards of the Body
Scientists earlier knew that some of these problematic white blood cells were destroyed in the immune organ—the site where white blood cells mature.
The latest award recognizes the identification of T-reg cells—described as the body's "peacekeepers"—which patrol the body to neutralize any defenders that attack the body's own tissues.
It is known that this mechanism fails in self-attack conditions such as type-1 diabetes, MS, and rheumatoid arthritis.
The Nobel panel stated, "These findings have established a new field of investigation and spurred the creation of innovative treatments, for instance for tumors and immune disorders."
In cancer, T-regs block the body from attacking the growth, so research are aimed at reducing their numbers.
In autoimmune diseases, trials are exploring boosting regulatory T-cells so the organism is not being harmed. A comparable approach could also be effective in minimizing the risks of transplanted organ failure.
Innovative Studies
Professor Shimon Sakaguchi, of a Japanese institution, conducted experiments on rodents that had their thymus extracted, leading to autoimmune disease.
The researcher demonstrated that introducing immune cells from other animals could stop the illness—implying there was a mechanism for preventing defenders from attacking the host.
Dr. Brunkow, affiliated with the a research center in a US city, and Dr. Ramsdell, currently at a biotech firm in a California city, were investigating an genetic immune disorder in mice and people that led to the discovery of a gene vital for the way T-regs operate.
"Their pioneering research has uncovered how the body's defenses is kept in check by regulatory T cells, stopping it from accidentally targeting the healthy cells," said a leading physiology specialist.
"This research is a striking example of how fundamental physiological research can have far-reaching implications for public health."